Estrogen receptor polymorphisms and the vascular effects of hormone therapy. - Wikidata - awgldk - TriplyDB

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

http://www.wikidata.org/entity/Q34782068

about

Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease.Genetics of cardiovascular disease: Importance of sex and ethnicity.Relationships of coronary heart disease with 27-hydroxycholesterol, low-density lipoprotein cholesterol, and menopausal hormone therapy.Pharmacogenomics of estrogens on changes in carotid artery intima-medial thickness and coronary arterial calcification: Kronos Early Estrogen Prevention Study.Women's Health Initiative Hormone Therapy Trials: New insights on Cardiovascular Disease from Additional Years of Follow up Influence of SULT1A1 genetic variation on age at menopause, estrogen levels, and response to hormone therapy in recently postmenopausal white women.Sex hormone therapy and progression of cardiovascular disease in menopausal women Association between estrogen receptor alpha c.454-397T>C and c.454-351A>G and ischemic stroke risk: a systematic review and meta-analysis.Hormones and venous thromboembolism among postmenopausal women.

P2860

Q35282590-87C2D8BE-FCB2-40B7-BA52-D27E53336A80 Q35738812-F9D1048E-469D-4CD6-9443-B0EB545F6B24 Q36352735-48460643-1ECE-4CBF-883F-77A6DB0280EC Q36589449-01714503-B8E7-4C1A-8553-8866D2A05666 Q36839180-773A09B3-E2E1-4712-8EDD-7D5F329362C1 Q37127079-DD904754-065D-4A49-8CB0-AC4111128342 Q37651567-0C0C8676-BC77-4B93-A77E-3B128DDCC5BC Q38023721-11960113-3211-464A-BDDA-58F15679F0F2 Q38249888-79370209-DE45-47C1-97E3-B10FB5F6D2D6

P2860

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

http://www.wikidata.org/entity/Q34782068

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

@ast

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

@en

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

@nl

type

label

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

@ast

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

@en

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

@nl

prefLabel

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

@ast

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

@en

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

@nl

P1433

Q34782068-F5DF82C9-6566-4195-8C1E-77E9EC05F2D1

P1476

Q34782068-DD3ECF08-3C6D-4005-8CE2-5AA6EAAE5643

P2093

Q34782068-10C7C26E-E325-4A20-9105-43BD3622DAB8

Q34782068-312AA6FB-1635-4F0D-A2F2-79E714A7EA60

Q34782068-3254E6B9-2935-43A4-B9D4-2D330C149784

Q34782068-39C6EE0F-3F61-451B-9BE4-1D31AB6B50C1

Q34782068-47ACD085-6A4D-4075-8FE6-622C7230A65B

Q34782068-657E3BDC-978A-4864-9711-E6CDE4914EAE

Q34782068-995713EC-9918-4A9F-8EF8-172B8192380A

Q34782068-9C03C623-E938-4720-8CE5-705AAA513212

Q34782068-B9BF15A4-856C-4E0D-B318-785B59D6D7A3

P2860

Q34782068-039D1248-7A5F-4D81-8D5E-51D7D07435D0

Q34782068-15105E58-41E1-4615-9F3C-FF197FF131AF

Q34782068-18E80167-A09F-4670-9D2D-A6D28FD0201A

Q34782068-22FB0379-23E2-4294-BDF5-9EF286321B12

Q34782068-232AE7B1-76DA-45F9-99D3-E1BDBFC2FFB3

Q34782068-27DD527E-1959-42A1-BA64-882D3D51411E

Q34782068-4E9C89E8-BB1D-49C6-A18E-E4EBF31F2B78

Q34782068-5A0F46C1-DCDB-497D-B47B-33A8E74C9641

Q34782068-6ACB2986-8470-4D4B-BCED-2CB7FBD39731

Q34782068-6CB25BF0-00B0-4F84-BAA7-B76EED5E276A

P304

Q34782068-3DF61582-B680-4BE6-8541-395931B49A2E

P31

Q34782068-CF59C9C9-AA33-4CD5-BD57-67D101C1A043

P356

Q34782068-1B45032A-8A73-4A5F-8FA4-181AE3E80389

P407

Q34782068-524D11D5-9E9A-4FEB-81A5-98479E457147

P433

Q34782068-849639C5-8C3F-4F47-A87A-1C0A1886B51C

P478

Q34782068-5CC3016B-C34A-4285-A946-C676CAAD8E5E

P50

Q34782068-32E59FF9-117D-45AD-9D1B-C2619F113463

Q34782068-9D6D607E-58C8-4F09-8369-5AD1D88CCC07

Q34782068-F442D5BD-7154-46F0-81A5-BB788892F9AC

P577

Q34782068-4A2DD82F-45F0-4B40-9622-2F56F866A04D

P5875

Q34782068-7143E96B-B344-41D5-8EA5-1E590DD61524

P698

Q34782068-96FABD02-FF44-4F60-9569-C7F4989D27BF

P932

Q34782068-541089D4-6BB7-42BD-8765-7BFAEE6EB196

P356

ATVBAHA.110.215087

P1433

Arteriosclerosis, Thrombosis, and Vascular Biology

P1476

Estrogen receptor polymorphisms and the vascular effects of hormone therapy.

@en

P2093

David Herrington

http://www.w3.org/2001/XMLSchema#string

Denise Bonds

http://www.w3.org/2001/XMLSchema#string

George Papanicolaou

http://www.w3.org/2001/XMLSchema#string

Jacques Rossouw

http://www.w3.org/2001/XMLSchema#string

Jingmin Liu

http://www.w3.org/2001/XMLSchema#string

Judith Hsia

http://www.w3.org/2001/XMLSchema#string

Paul Bray

http://www.w3.org/2001/XMLSchema#string

Susan Hendrix

http://www.w3.org/2001/XMLSchema#string

Timothy Howard

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

Can biomarkers identify women at increased stroke risk? The Women's Health Initiative Hormone Trials

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

Estrogen receptor alpha polymorphism and venous thromboembolism in male and female: data from the EDITH study.

Estrogen plus progestin and the risk of coronary heart disease.

A comparison of linkage disequilibrium measures for fine-scale mapping.

Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women

Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events

ESR1 polymorphism is associated with plasma lipid and apolipoprotein levels in Caucasians of the Rochester Family Heart Study.

P304

464-469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/ATVBAHA.110.215087

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Charles Kooperberg

P577

2010-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49635179

http://www.w3.org/2001/XMLSchema#string

P698

21106950

http://www.w3.org/2001/XMLSchema#string

P932

3074605

http://www.w3.org/2001/XMLSchema#string